Diabetes Therapy, 11(6), 1251-1269
While theres debate about how it works, the addition of GIP in this case may be increasing the effectiveness of GLP-1, creating an added weight loss effect
"It does add to the growing body of evidence suggesting that it's worth investigating these weight loss drugs as potential cancer prevention tools." McDonald and her collaborators are now working on a clinical trial to test whether these drugs can lower breast cancer incidence in women who are at high risk
[56] [57] Der Ausschuss fr Risikobewertung im Bereich der Pharmakovigilanz der Europischen Arzneimittel-Agentur (Pharmacovigilance Risk Assessment Committee, PRAC) erklrte im Juni 2025 nach Abschluss der berprfung semaglutidhaltiger Arzneimittel, dass die nicht-arterielle anteriore ischmische Optikusneuropathie (NAION) als eine sehr seltene Nebenwirkung von Semaglutid anzusehen ist (bis zu 1 von 10.000)
GLPro Blood Sugar Formula is a dietary supplement designed to help people maintain healthier blood sugar levels
announced that approximately 14 of 19 previously restricted peptides reportedly including BPC-157 are expected to be moved back to Category 1 status, which would restore legal compounding pharmacy access
